AB
CATX icon

Amalgamated Bank’s Perspective Therapeutics CATX Stock Holding History

Amalgamated Bank’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,872
Closed -$5K – 1828
2025
Q4 		$5K Buy
1,872
+243
+15% +$693 ﹤0.01% 2696
2025
Q3 		$6K Hold
1,629
– – ﹤0.01% 2660
2025
Q2 		$6K Hold
1,629
– – ﹤0.01% 2633
2025
Q1 		$3K Hold
1,629
– – ﹤0.01% 2771
2024
Q4 		$5K Hold
1,629
– – ﹤0.01% 2709
2024
Q3 		$22K Hold
1,629
– – ﹤0.01% 2091
2024
Q2 		$16K Buy
+1,629
New +$23.6K ﹤0.01% 2206

Other funds holding CATX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Amalgamated Bank's CATX Position: Q1 2026 in Review

Amalgamated Bank sold out of Perspective Therapeutics (CATX) in Q1 2026, closing a stake of 1,872 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in CATX in Q2 2024 and held it in 7 quarters. The position peaked at $22K in Q3 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Amalgamated Bank reported no remaining Perspective Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,872 Perspective Therapeutics shares in Q1 2026, an estimated $5K.
  • Amalgamated Bank first reported a position in Perspective Therapeutics in Q2 2024 and held it in 7 quarters.
  • Amalgamated Bank's Perspective Therapeutics position peaked at $22K in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.